Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers
Thomas Schluep, Jason D. Lickliter, James Hamilton, et al.
Clinical Pharmacology in Drug Development (2016) Vol. 6, Iss. 4, pp. 350-362
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

The current state and future directions of RNAi-based therapeutics
Ryan L. Setten, John J. Rossi, Si‐ping Han
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 6, pp. 421-446
Closed Access | Times Cited: 1168
Therapeutic siRNA: state of the art
Bo Hu, Liping Zhong, Yuhua Weng, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1089
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell, Man‐Fung Yuen, Henry Lik‐Yuen Chan, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 409
Open Access | Times Cited: 408
RNA interference-based therapy and its delivery systems
Xiuhui Chen, Lingegowda S. Mangala, Cristian Rodriguez‐Aguayo, et al.
Cancer and Metastasis Reviews (2017) Vol. 37, Iss. 1, pp. 107-124
Open Access | Times Cited: 266
siRNA therapeutics: a clinical reality
Phei Er Saw, Erwei Song
Science China Life Sciences (2019) Vol. 63, Iss. 4, pp. 485-500
Closed Access | Times Cited: 252
Nucleic acid delivery for therapeutic applications
Akash Gupta, Jason L. Andresen, Rajith S. Manan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113834-113834
Closed Access | Times Cited: 219
HIV-hepatitis B virus coinfection
Kasha P. Singh, Megan Crane, Jennifer Audsley, et al.
AIDS (2017) Vol. 31, Iss. 15, pp. 2035-2052
Open Access | Times Cited: 206
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ludger M. Ickenstein, Patrick Garidel
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 11, pp. 1205-1226
Closed Access | Times Cited: 166
RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection
Man‐Fung Yuen, Ingolf Schiefke, Jung‐Hwan Yoon, et al.
Hepatology (2019) Vol. 72, Iss. 1, pp. 19-31
Open Access | Times Cited: 106
Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection
Yuchen Xia, T. Jake Liang
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 311-324
Open Access | Times Cited: 103
RNA Interference as a Prospective Tool for the Control of Human Viral Infections
Alesia A. Levanova, Minna M. Poranen
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 96
Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand
Mala K. Maini, Laura J. Pallett
˜The œLancet. Gastroenterology & hepatology (2018) Vol. 3, Iss. 3, pp. 192-202
Open Access | Times Cited: 85
Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
Wanyi Tai
Molecules (2019) Vol. 24, Iss. 12, pp. 2211-2211
Open Access | Times Cited: 78
Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics
Milica Marković, Shimon Ben‐Shabat, Aaron Aponick, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3248-3248
Open Access | Times Cited: 72
Viral hepatitis: Past, present, and future
Matthew A. Odenwald, Sonali Paul
World Journal of Gastroenterology (2022) Vol. 28, Iss. 14, pp. 1405-1429
Open Access | Times Cited: 66
RNA interference as a novel treatment strategy for chronic hepatitis B infection
Rex Wan‐Hin Hui, Lung‐Yi Mak, Wai‐Kay Seto, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 3, pp. 408-424
Open Access | Times Cited: 60
RNA Therapeutics - Research and Clinical Advancements
Rundong Feng, Suryaji Patil, Xin Zhao, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 56
Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine
Ellen S. Smith, Eric Whitty, Byunghee Yoo, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1588-1588
Open Access | Times Cited: 48
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
Sheyda Ranjbar, Xiao‐bo Zhong, José E. Manautou, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115052-115052
Open Access | Times Cited: 28
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects
Laura Sneller, Christine Y. Lin, Angie Price, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 599-599
Open Access | Times Cited: 11
Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review
Hamid Motamedi, Marzie Mahdizade Ari, Amirhoushang Alvandi, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 8
Review Article: Assessing the virological response to direct-acting antiviral therapies in the HBV cure programme.
James Lok, James Michael Harris, Ivana Carey, et al.
Virology (2025) Vol. 605, pp. 110458-110458
Closed Access | Times Cited: 1
Towards HBV curative therapies
Raymond F. Schinazi, Maryam Ehteshami, Leda Bassit, et al.
Liver International (2018) Vol. 38, Iss. S1, pp. 102-114
Open Access | Times Cited: 76
RNA Therapeutics in Cardiovascular Precision Medicine
Ageliki Laina, Aikaterini Gatsiou, Georgios Georgiopoulos, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 75
Updates on Chronic HBV: Current Challenges and Future Goals
Hannah M. Lee, Bubu A. Banini
Current Treatment Options in Gastroenterology (2019) Vol. 17, Iss. 2, pp. 271-291
Closed Access | Times Cited: 65
Page 1 - Next Page

Scroll to top